Lipopolysaccharide signaling through the Toll-like receptors downregulates an inhibitory pseudoreceptor of TGF-β, enhancing hepatic fibrosis and liver injury (pages 1324–1332). Chronic liver disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results